FEATURED COMPANIES
- B. Braun Melsungen
- Johnson & Johnson
- Medtronic
- Smith & Nephew
- Stryker
- Zimmer Biomet
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Increasing focus on customizing material properties to drive growth in the market. There is a growing focus on customizing the material properties of composite and bioabsorbable materials with fillers like bioactive ceramics for nonpermanent devices. PEEK biomaterials, which are variations of PAEK biomaterials, have been used in spinal implants, and as bearing materials for hip and knee replacement, and hip resurfacing. The analysts have predicted that the orthopedic biomaterials market will register a CAGR of close to 7% by 2022.
Market Overview
Increasing prevalence of musculoskeletal diseases and disorders
The increasing burden of musculoskeletal disorders subsequently increases the demand for orthopedic biomaterials used to repair such conditions.
High cost of orthopedic bioimplants and surgeries
The high cost of orthopedic bioimplants and surgeries is restricting the widespread adoption of orthopedic biomaterials in several developed as well as developing countries.
For the detailed list of factors that will drive and challenge the growth of the orthopedic biomaterials market during the 2018-2022, view this report.
Competitive Landscape
The market appears to be fragmented and with the presence of several companies including Medtronic and Smith & Nephew, the competitive environment is quite intense. Factors such as the increasing prevalence of musculoskeletal diseases and disorders and the increasing focus on customizing material properties, will provide considerable growth opportunities to orthopedic biomaterials manufactures. B. Braun Melsungen, Johnson & Johnson, Medtronic, Smith & Nephew, Stryker, and Zimmer Biomet are some of the major companies covered in this report.
Market Overview
Increasing prevalence of musculoskeletal diseases and disorders
The increasing burden of musculoskeletal disorders subsequently increases the demand for orthopedic biomaterials used to repair such conditions.
High cost of orthopedic bioimplants and surgeries
The high cost of orthopedic bioimplants and surgeries is restricting the widespread adoption of orthopedic biomaterials in several developed as well as developing countries.
For the detailed list of factors that will drive and challenge the growth of the orthopedic biomaterials market during the 2018-2022, view this report.
Competitive Landscape
The market appears to be fragmented and with the presence of several companies including Medtronic and Smith & Nephew, the competitive environment is quite intense. Factors such as the increasing prevalence of musculoskeletal diseases and disorders and the increasing focus on customizing material properties, will provide considerable growth opportunities to orthopedic biomaterials manufactures. B. Braun Melsungen, Johnson & Johnson, Medtronic, Smith & Nephew, Stryker, and Zimmer Biomet are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- B. Braun Melsungen
- Johnson & Johnson
- Medtronic
- Smith & Nephew
- Stryker
- Zimmer Biomet
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
PART 09: REGIONAL LANDSCAPE
PART 11: DRIVERS AND CHALLENGES
Exhibit 01: Global biomaterials market: Parent market
Exhibit 02: Global biomaterials market: Segmentation
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Global orthopedic biomaterials market 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global orthopedic biomaterials market - Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global orthopedic biomaterials market - Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global orthopedic biomaterials market by application - Market share 2017-2022 (%)
Exhibit 19: Global orthopedic biomaterials market - Comparison by application
Exhibit 20: Joint replacement - Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Joint replacement - Year-over-year growth 2018-2022 (%)
Exhibit 22: Osteosynthesis - Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Osteosynthesis - Year-over-year growth 2018-2022 (%)
Exhibit 24: Orthobiologics - Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Orthobiologics - Year-over-year growth 2018-2022 (%)
Exhibit 26: Spine implants - Market size and forecast 2017-2022 ($ mn)
Exhibit 27: Spine implants - Year-over-year growth 2018-2022 (%)
Exhibit 28: Market opportunity by application
Exhibit 29: Customer landscape
Exhibit 30: Global orthopedic biomaterials market - Market share by geography 2017-2022 (%)
Exhibit 31: Global orthopedic biomaterials market - Regional comparison
Exhibit 32: Orthopedic biomaterials market in Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 33: Orthopedic biomaterials market in Americas - Year-over-year growth 2018-2022 (%)
Exhibit 34: Top three countries in Americas
Exhibit 35: Orthopedic biomaterials market in EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 36: Orthopedic biomaterials market in EMEA - Year-over-year growth 2018-2022 (%)
Exhibit 37: Top three countries in EMEA
Exhibit 38: Orthopedic biomaterials market in APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 39: Orthopedic biomaterials market in APAC - Year-over-year growth 2018-2022 (%)
Exhibit 40: Top three countries in APAC
Exhibit 41: Market opportunity
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: B. Braun Melsungen - Overview
Exhibit 48: B. Braun Melsungen - Business segments
Exhibit 49: B. Braun Melsungen - Organizational developments
Exhibit 50: B. Braun Melsungen - Geographic focus
Exhibit 51: B. Braun Melsungen - Segment focus
Exhibit 52: B. Braun Melsungen - Key offerings
Exhibit 53: B. Braun Melsungen - Key customers
Exhibit 54: Johnson & Johnson - Overview
Exhibit 55: Johnson & Johnson - Business segments
Exhibit 56: Johnson & Johnson - Organizational developments
Exhibit 57: Johnson & Johnson - Geographic focus
Exhibit 58: Johnson & Johnson - Segment focus
Exhibit 59: Johnson & Johnson - Key offerings
Exhibit 60: Johnson & Johnson - Key customers
Exhibit 61: Medtronic - Overview
Exhibit 62: Medtronic - Business segments
Exhibit 63: Medtronic - Organizational developments
Exhibit 64: Medtronic - Geographic focus
Exhibit 65: Medtronic - Segment focus
Exhibit 66: Medtronic - Key offerings
Exhibit 67: Medtronic - Key customers
Exhibit 68: Smith & Nephew - Overview
Exhibit 69: Smith & Nephew - Business segments
Exhibit 70: Smith & Nephew - Organizational developments
Exhibit 71: Smith & Nephew - Geographic focus
Exhibit 72: Smith & Nephew - Segment focus
Exhibit 73: Smith & Nephew - Key offerings
Exhibit 74: Smith & Nephew - Key customers
Exhibit 75: Stryker - Overview
Exhibit 76: Stryker - Business segments
Exhibit 77: Stryker - Organizational developments
Exhibit 78: Stryker - Geographic focus
Exhibit 79: Stryker - Segment focus
Exhibit 80: Stryker - Key offerings
Exhibit 81: Stryker - Key customers
Exhibit 82: Zimmer Biomet - Overview
Exhibit 83: Zimmer Biomet - Products segments
Exhibit 84: Zimmer Biomet - Organizational developments
Exhibit 85: Zimmer Biomet - Geographic focus
Exhibit 86: Zimmer Biomet - Segment focus
Exhibit 87: Zimmer Biomet - Key offerings
Exhibit 88: Zimmer Biomet - Key customers
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Segmentation by application
- Comparison by application
- Joint replacement
- Osteosynthesis
- Orthobiologics
- Spine implants
- Market opportunity by application
PART 09: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Orthopedic biomaterials market in Americas
- Orthopedic biomaterials market in EMEA
- Orthopedic biomaterials market in APAC
- Market opportunity
PART 11: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
- Increasing use of nanoparticles in orthopedic bioimplants
- Increasing focus on customizing material properties
- Overview
- Landscape disruption
- Vendors covered
- Vendor classification
- Market positioning of vendors
- B. Braun Melsungen
- Johnson & Johnson
- Medtronic
- Smith & Nephew
- Stryker
- Zimmer Biomet
- List of abbreviations
Exhibit 01: Global biomaterials market: Parent market
Exhibit 02: Global biomaterials market: Segmentation
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Global orthopedic biomaterials market 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global orthopedic biomaterials market - Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global orthopedic biomaterials market - Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global orthopedic biomaterials market by application - Market share 2017-2022 (%)
Exhibit 19: Global orthopedic biomaterials market - Comparison by application
Exhibit 20: Joint replacement - Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Joint replacement - Year-over-year growth 2018-2022 (%)
Exhibit 22: Osteosynthesis - Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Osteosynthesis - Year-over-year growth 2018-2022 (%)
Exhibit 24: Orthobiologics - Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Orthobiologics - Year-over-year growth 2018-2022 (%)
Exhibit 26: Spine implants - Market size and forecast 2017-2022 ($ mn)
Exhibit 27: Spine implants - Year-over-year growth 2018-2022 (%)
Exhibit 28: Market opportunity by application
Exhibit 29: Customer landscape
Exhibit 30: Global orthopedic biomaterials market - Market share by geography 2017-2022 (%)
Exhibit 31: Global orthopedic biomaterials market - Regional comparison
Exhibit 32: Orthopedic biomaterials market in Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 33: Orthopedic biomaterials market in Americas - Year-over-year growth 2018-2022 (%)
Exhibit 34: Top three countries in Americas
Exhibit 35: Orthopedic biomaterials market in EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 36: Orthopedic biomaterials market in EMEA - Year-over-year growth 2018-2022 (%)
Exhibit 37: Top three countries in EMEA
Exhibit 38: Orthopedic biomaterials market in APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 39: Orthopedic biomaterials market in APAC - Year-over-year growth 2018-2022 (%)
Exhibit 40: Top three countries in APAC
Exhibit 41: Market opportunity
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: B. Braun Melsungen - Overview
Exhibit 48: B. Braun Melsungen - Business segments
Exhibit 49: B. Braun Melsungen - Organizational developments
Exhibit 50: B. Braun Melsungen - Geographic focus
Exhibit 51: B. Braun Melsungen - Segment focus
Exhibit 52: B. Braun Melsungen - Key offerings
Exhibit 53: B. Braun Melsungen - Key customers
Exhibit 54: Johnson & Johnson - Overview
Exhibit 55: Johnson & Johnson - Business segments
Exhibit 56: Johnson & Johnson - Organizational developments
Exhibit 57: Johnson & Johnson - Geographic focus
Exhibit 58: Johnson & Johnson - Segment focus
Exhibit 59: Johnson & Johnson - Key offerings
Exhibit 60: Johnson & Johnson - Key customers
Exhibit 61: Medtronic - Overview
Exhibit 62: Medtronic - Business segments
Exhibit 63: Medtronic - Organizational developments
Exhibit 64: Medtronic - Geographic focus
Exhibit 65: Medtronic - Segment focus
Exhibit 66: Medtronic - Key offerings
Exhibit 67: Medtronic - Key customers
Exhibit 68: Smith & Nephew - Overview
Exhibit 69: Smith & Nephew - Business segments
Exhibit 70: Smith & Nephew - Organizational developments
Exhibit 71: Smith & Nephew - Geographic focus
Exhibit 72: Smith & Nephew - Segment focus
Exhibit 73: Smith & Nephew - Key offerings
Exhibit 74: Smith & Nephew - Key customers
Exhibit 75: Stryker - Overview
Exhibit 76: Stryker - Business segments
Exhibit 77: Stryker - Organizational developments
Exhibit 78: Stryker - Geographic focus
Exhibit 79: Stryker - Segment focus
Exhibit 80: Stryker - Key offerings
Exhibit 81: Stryker - Key customers
Exhibit 82: Zimmer Biomet - Overview
Exhibit 83: Zimmer Biomet - Products segments
Exhibit 84: Zimmer Biomet - Organizational developments
Exhibit 85: Zimmer Biomet - Geographic focus
Exhibit 86: Zimmer Biomet - Segment focus
Exhibit 87: Zimmer Biomet - Key offerings
Exhibit 88: Zimmer Biomet - Key customers
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- B. Braun Melsungen
- Johnson & Johnson
- Medtronic
- Smith & Nephew
- Stryker
- Zimmer Biomet
Global Orthopedic Biomaterials Market 2018-2022
The analyst recognizes the following companies as the key players in the global orthopedic biomaterials market: B. Braun Melsungen, Johnson & Johnson, Medtronic, Smith & Nephew, Stryker, and Zimmer Biomet.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing focus on customizing material properties.”
According to the report, one of the major drivers for this market is the increasing prevalence of musculoskeletal diseases and disorders.
Further, the report states that one of the major factors hindering the growth of this market is the high cost of orthopedic bioimplants and surgeries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
The analyst recognizes the following companies as the key players in the global orthopedic biomaterials market: B. Braun Melsungen, Johnson & Johnson, Medtronic, Smith & Nephew, Stryker, and Zimmer Biomet.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing focus on customizing material properties.”
According to the report, one of the major drivers for this market is the increasing prevalence of musculoskeletal diseases and disorders.
Further, the report states that one of the major factors hindering the growth of this market is the high cost of orthopedic bioimplants and surgeries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
- B. Braun Melsungen
- Johnson & Johnson
- Medtronic
- Smith & Nephew
- Stryker
- Zimmer Biomet
Note: Product cover images may vary from those shown
LOADING...
